Compare PMCB & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PMCB | AMBO |
|---|---|---|
| Founded | 1996 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3M | 7.2M |
| IPO Year | 2001 | 2010 |
| Metric | PMCB | AMBO |
|---|---|---|
| Price | $0.69 | $1.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 112.4K | 10.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 277.22 | ★ 337.04 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $9,469,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $69.07 |
| Revenue Growth | N/A | ★ 0.82 |
| 52 Week Low | $0.63 | $1.47 |
| 52 Week High | $1.73 | $6.75 |
| Indicator | PMCB | AMBO |
|---|---|---|
| Relative Strength Index (RSI) | 46.59 | 36.09 |
| Support Level | $0.65 | $1.47 |
| Resistance Level | $0.77 | $3.15 |
| Average True Range (ATR) | 0.06 | 0.18 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 42.23 | 18.60 |
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.